|Vaccine (journal) (Photo credit: Wikipedia)|
"It can be more serious than you think," says a brochure handed out at doctors' offices across the United States. "And you may be at risk." The brochure is for Prevar 13, a vaccine designed to protect against 13 strains of pneumococcal pneumonia. People as young as 50 are at risk, it continues as it urges immunization for adults 50 years and older, and for children six weeks to five years of age. But even the brochure that advocates vaccination admits, "There have been no controlled trials in adults demonstrating a decrease in pneumococcal pneumonia or invasive disease after vaccination with Prevnar 13."
Wait ... doctors are urging tens of millions of people to have this vaccine, yet there are no trials proving that it is effective? "Yes," says Dr. David Brownstein, author of the newsletter Dr. Brownstein's Natural Way to Health. "We don't have any proof that this vaccine works," he tells Newsmax Health. "In fact, there's hardly any information on this vaccine at all.
"I think it is shameful that this vaccine is recommended for prevention of pneumonia when there are no controlled studies showing it is effective," he says. "This is another example of a poorly studied vaccine — just like there are no controlled studies on the flu vaccine, either."
Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Headline/pneumococcal-pneumonia-DrDavid-Brownstein-vaccines-Prevnar-13/2013/06/19/id/510814#ixzz2WlPTL9JW
Alert: What Is Your Risk for a Heart Attack? Find Out Now